Report Overview:
The Global Epigenetics Market achieved a valuation of $1.9 Billion in 2022 and is anticipated to exceed $4.41 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 12.8% during the forecast period from 2024 to 2032.
Key Market Players:
Illumina (US), Thermo Fisher Scientific (US), Merck Millipore (US), Abcam (UK), Active Motif (US), Bio-Rad...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek